Lee, W. S., Yang, H., Chon, H. J., & Kim, C. (2020). Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity. Experimental & molecular medicine, 52(9), 1475-1485. https://doi.org/10.1038/s12276-020-00500-y
Chicago Style (17th ed.) CitationLee, Won Suk, Hannah Yang, Hong Jae Chon, and Chan Kim. "Combination of Anti-angiogenic Therapy and Immune Checkpoint Blockade Normalizes Vascular-immune Crosstalk to Potentiate Cancer Immunity." Experimental & Molecular Medicine 52, no. 9 (2020): 1475-1485. https://doi.org/10.1038/s12276-020-00500-y.
MLA (9th ed.) CitationLee, Won Suk, et al. "Combination of Anti-angiogenic Therapy and Immune Checkpoint Blockade Normalizes Vascular-immune Crosstalk to Potentiate Cancer Immunity." Experimental & Molecular Medicine, vol. 52, no. 9, 2020, pp. 1475-1485, https://doi.org/10.1038/s12276-020-00500-y.